Sponsor pipeline

AFT Pharmaceuticals, Ltd. clinical trial pipeline

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Phase 2		1
Phase 3		3

NCT ID	Title	Condition	Status	Updated
Phase 3
NCT07225634	A Study of Combogesic® IV (Intravenous) in Pediatric Patients With Acute Pain	Acute Pain	Recruiting	2026-09-16
NCT07687784	A Study to Test the Non-Inferiority of Ferric Bepectate IV Against Ferric Carboxymaltose…	Iron Deficiency Anemia (IDA)	Not Yet Recruiting	2026-08-20
NCT07225140	A Study of Combogesic® 325 in Adolescent Patients With Moderate to Severe Postoperative…	Post Operative Pain, Acute	Not Yet Recruiting	2026-07-01
Phase 2
NCT07436611	Rapamycin Dose-Ranging Efficacy Study in Port Wine Stains	Port Wine Stains	Not Yet Recruiting	2026-07-01

Get alerts when AFT Pharmaceuticals, Ltd.'s trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.